Superb Microvascular Intraocular Tumor Imaging Study (SMITIS)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-27

Study Completion Date

2026-01-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The diagnosis and monitoring of intraocular tumors are based on multimodal imaging in addition to the clinical examination (ultra-widefield retinal imaging, echography, angiography). Nevertheless, it may be difficult in cases of retinal hemorrhage, small tumor size or atypical presentation. The study of microvascular flow (Superb Microvascular Imaging, SMI) of intraocular tumors could improve the confidence of differential diagnosis when evaluating these suspicious lesions, or even determine whether a lesion is benign or malignant by describing the vascularization of the lesion.

The investigators propose to study the microvascular flow patterns of intraocular tumors prior to proton therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases

NCT01546181

Retinal Dystrophies Age-related Macular Degeneration Arterial Hypertension +3 more

COMPLETED

Blood Vessel Patterns in Small Choroidal Tumors

NCT01955915

Small Posterior Choroidal Tumors

UNKNOWN

Vascular Changes Associated With Endophthalmitis.

NCT07175311

Endophthalmitis

RECRUITING

Molecular Imaging Exploration of Ocular Angiogenic Activity and Evaluation of Its Interest in the Therapeutic Follow-up of Patients With AMD (Age-related Macular Degeneration)

NCT04005443

Age Related Macular Degeneration

UNKNOWN NA

Definity for Ultrasound of Intraocular Tumors

NCT01930968

Ocular Melanoma

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ultrasound equipment available in ophthalmology does not have Doppler technology and does not allow the study of the vascularization and microvascularization of intraocular lesions. The interest in the system used in this study is to import SMI into ophthalmology to study tumor microvascularization. The study of tumor vascularization can help in the differential diagnosis and follow-up of tumors, and therefore can impact the management of patients with tumors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ocular Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intraocular tumor

New sonographic software technique on ultrasonography to detect low-vascular flow inside intraocular tumors

Group Type EXPERIMENTAL

Doppler technology

Intervention Type DIAGNOSTIC_TEST

The study of tumor vascularization can help in the differential diagnosis and follow-up of tumors, and therefore can impact the management of patients with tumors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doppler technology

The study of tumor vascularization can help in the differential diagnosis and follow-up of tumors, and therefore can impact the management of patients with tumors

Intervention Type DIAGNOSTIC_TEST